Teneligliptin (MP-513) is a novel dipeptidyl peptidase 4 (DPP IV) inhibitor for the treatment of type 2 diabetes mellitus with hypoglycemic activity for the study of obesity and diabetes.
Molecular Weight:
426.58
Purity:
99.73%
CAS Number:
[760937-92-6]
Formula:
C22H30N6OS
Target:
Proteasome|||DPP-4
T37522
T37522
* VAT and and shipping costs not included. Errors and price changes excepted